COVID-19 Uninsured Claims Reimbursement for Testing and Treatment

June 04, 2020

According to the Health Resources & Services Administration (HRSA), providers who have conducted COVID-19 testing or provided treatment for uninsured COVID-19 individuals on or after Feb. 4, 2020 can request claims reimbursement through the HRSA online portal and will be reimbursed generally at Medicare rates, subject to available funding. In general, reimbursement will be available for COVID-19 testing and testing-related visits for uninsured individuals, as well as treatment for uninsured individuals with a primary COVID-19 diagnosis as determined by HRSA.
Assignment of primary diagnosis for COVID-19 is date dependent. For dates of services through March 31, 2020, current coding guidelines take precedence for patients presenting with signs, symptoms, exposure and/or definitive diagnosis related to respiratory illness or disease. CMS created a new diagnosis code, effective April 1, 2020, to report COVID-19 cases: U07.1. – 2019 nCOV acute respiratory disease.
Eligibility for payment is subject to terms and conditions of participation in the CARES Act Provider Relief Fund. Click here for more information.

This story originally appeared in the June 04, 2020 edition of WHA Newsletter